A detailed history of Group One Trading, L.P. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 5,548 shares of RVMD stock, worth $314,849. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,548
Previous 5,841 5.02%
Holding current value
$314,849
Previous $226,000 11.06%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.92 - $47.94 $10,817 - $14,046
-293 Reduced 5.02%
5,548 $251,000
Q2 2024

Aug 14, 2024

BUY
$30.14 - $40.68 $176,047 - $237,611
5,841 New
5,841 $226,000
Q4 2023

Feb 14, 2024

BUY
$18.35 - $34.12 $56,664 - $105,362
3,088 New
3,088 $88,000
Q1 2023

May 12, 2023

BUY
$20.76 - $30.09 $4,940 - $7,161
238 New
238 $5,000
Q3 2022

Nov 09, 2022

BUY
$17.46 - $26.0 $3,492 - $5,200
200 Added 0.96%
21,000 $414,000
Q2 2022

Aug 11, 2022

BUY
$14.54 - $27.17 $302,432 - $565,136
20,800 New
20,800 $405,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.98B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.